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ABSTRACT
￿
The transport of a-aminoisobutyric acid (AIB) by rat hepatoma tissue culture (HTC)
cells is rapidly and reversibly inhibited by dexamethasone and other glucocorticoids. To
investigate the role of the nucleus in the regulation of transport and to determine whether
steroid hormones or steroid-receptor complexes may have direct effects on cytoplasmic or
membrane functions, we have examined the regulation of transport by dexamethasone in
anucleate HTC cells. Cytoplasts prepared from suspension cultures of HTC cells fully retain
active transport of AIB with the same kinetic properties as intact cells. However, the uptake of
AIB is not inhibited by dexamethasone or other corticosteroids. Neither is the inhibited rate of
transport, manifested by cytoplasts prepared from dexamethasone-treated cells, restored to
normal upon removal of the hormone. Anucleate cells exhibit specific, saturable binding of
[3H]dexamethasone; however, the binding is reduced compared with that of intact cells. The
nucleus is thus required for the glucocorticoid regulation of amino acid transport in HTC cells.
Incubation ofrat hepatoma tissue culture (HTC cells with the
synthetic glucocorticoid dexamethasone elicits a program of
changes in membrane function (3, 8). Included among these is
the rapid and reversible inhibition of the initial rate of uptake
of several amino acids transported by the A-system for neutral
amino acids (16, 18, 19). On the basis of studies with the
macromolecular synthesis inhibitors cycloheximide and acti-
nomycin D, we have proposed a model in which glucocorticoids
act to enhance the rate ofdegradation of a rate-limiting protein
in the transport system (8, 16). Glucocorticoids are believed to
influence cell functions via interactions with specific cytoplas-
mic receptors which, when bound with steroid, can associate
with acceptor sites in the nucleus and initiate transcriptional
activation of specific genes (20, 21). However, the possibility
that steroid hormones or steroid-receptor complexes may have
direct effects on cytoplasmic or membrane functions has not
been excluded, and indeed there is evidence for such direct
hormonal actions (2, 13).
To study this latter possibility directly, we have enucleated
HTC cells in suspension culture and examined the dexameth-
asone regulation of transport of the nonmetabolized amino
acid a-aminoisobutyric acid (AIB). Anucleate HTC cells retain
fullytheir capacity to transport AIB; however, dexamethasone
fails to inhibit transport in cytoplasts. Cytoplasts prepared from
cells previously incubated with dexamethasone show an in-
hibited level of AIB transport; but, in contrast to intact cells,
the rate of transport is not restored to control levels upon
removal of the steroid. An intact nucleus is thus required for
the glucocorticoid regulation of amino acid transport in HTC
cells.
MATERIALS AND METHODS
Cells and Media
HTC cells, an established line of rat hepatoma cells, were grown in spinner
culture, without antibiotics, in Eagle's Minimal Essential Medium (autoclavable
powder; Grand Island Biological Co., Grand Island, New York), modified as
described by Heaton and Gelehrter (11). For experiments, cells were resuspended
at 108 cells/ml in Induction Medium-bovine serum albumin (IM-BSA; serum-
free growth medium supplemented with I mg/ml bovine serum albumin and 50
mg/literneomycin) and incubated in a gyrotoryshaker water bath at 37°C for6-
18 h before further treatment. Routinely, 9498% of the cells excluded trypan
blue after 2448 h ofincubation in IM-BSA.
Enucleation of HTC Cells
HTC cells were enucleated by centrifuging cytoehalasin B-treated cells
through a Ficoll gradient, using a proceduremodifiedfromWiglerandWeinstein
(24, 25). An aqueous 50% stock solution ofFicoll type 400 was diluted with IM-
BSA to prepare the components of the gradients; a refractometer was used to
check the final concentration of the gradient solutions. The gradients were
prepared in 3% x Brie inch cellulose nitrate tubes (Beckman Instrument Co.,
Spinco Div., Palo Alto, Calif) by carefully layering the following solutions of
Ficoll: 2 ml of 30%; 2 ml of 22%; 0.5 ml of20%, 0.5 ml of 18%; and 2 ml of 15%.
All components of the gradients contain 10 ug/ml cytochalasin B (21 WM)
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at 37°C for 16 h.
For six gradients, 3 x 10' cells were resuspended in 18 ml of 15% Ficoll
containing 10 ttg/ml cytochalasin B, and 3 ml of this suspension were carefully
layered onto each gradient (5 x 10' cells/gradient). Each tube was overlaid with
2 ml of IM-BSA containing cytochalasin B. Thegradient tubes were loaded onto
a SW-41 rotor, prewrmed to 37°C. Thecells were then centrifuged for 1 h at
25,000 rpm(^"100,000 g) in a Beckman L5-50 ultracentrifuge (Beckman Instru-
ment Co.) without refrigeration; the temperature in the chamber during the run
was 3l'-34°C. After centrifugation, the cytoplasts, which banded primarily in
the 20% region of the gradients, were removed, diluted with IM-BSA and
centrifuged to remove Ficoll and cytochalasin B, and resuspended in growth
medium or IM-BSA asrequired. Theconcentration ofcytoplasts was determined
by counting a sample ofsuspension in a hemocytometer. A sample ofcytoplast
suspension was also heat-fixed on a microscope slide and stained with 0.5%
acetoorcein to determine the efficiency ofthe enucleation procedure; 1,500-2,000
cells were scored for the numbers ofnucleated and nonnucleated cells.
Assays
Uptake of AIB was measured in a 1.1-ml sample of cell suspension in IM-
BSA, to which was added 0.5 pCi ["Cla-aminoisobutyric acid (51.6 mCi/mmol)
plus unlabeled AIB to a final concentration of 0.51 mM. After 10 minat 37°C,
duplicate 0.5-ml samples were removed, and the cells were pelleted by centrifu-
gation for 40 s at 8,000 g in an Eppendorf 3200 microcentrifuge (Brinkman
Instruments, Westbury, N. Y.). Thecell pellets were hydrolyzed with KOH and
analyzed for radioactivity (11, 16). Extracellular water in the cell pellets was
calculated from inulin space (trapped water) measurements; pellet radioactivity
was then corrected for trapped-supernate counts, and AIB transport velocity was
expressed as nmoles per minute per milligram of protein. Protein content of
KOH-hydrolyzed cell pellet samples was measured by the method of Lowry et
al. (14).
DNAand protein synthesis were measured by incubating cells or cytoplasts in
serum-free medium for 1 hat 37°C with 1 jLCi/ml [3H]thymidine (6.7 Ci/mol) or
3H-amino acid mixture (159 mCi/mg). Thymidine or amino acid incorporation
into TCA-precipitable materialwas measured andexpressedas countsper minute
per milligram ofprotein per hour.
Tyrosine aminotransferasewas assayedas described by Spencer and Gelehrter
(23). Activity is expressed as nmoles ofp-hydroxyphenylpyruvate formed per
minute per milligram of protein.
Binding of Dexamethasone to Cells and
Cytoplasts
Steroid binding to cells and cytoplasts was measured by aprocedure adapted
from Sibley and Tomkins (22). To tubes containing a total of 5-7 x 108 cells or
cytoplasts suspended in 0.5 ml of serum-free medium was added 5 nM ['H]-
dexamethasone (20.9 pCi/nmol) with or without 50 pM unlabeled dexametha-
sone. Thecell suspensions were incubated for 40 minat 37°C, then diluted with
3 ml ofice-cold phosphate-buffered saline and centrifuged at 1,200 g for 1 min
in a SorvallCW-1 centrifuge (DuPont Co., Sorvall BiomedicalDiv.,Wilmington,
Del.). Cell pellets were resuspended in 3 ml of cold saline, kept on ice for 2 min,
and then centrifuged. Thepelletswere dissolved in 0.7 ml of 1 NNaOH. Specific
binding is total radioactivity bound minus that bound in the presence of excess
unlabeled steroid, and is expressed as femtomoles per milligram ofprotein.
Binding of ['H]dexamethasone was also measured in lysates of cells or
cytoplasts by a procedure modified from that ofMacDonald and Cidlowski (15).
Frozen pellets ofcells or cytoplasts (containing 100-250 x 108 cells orcytoplasts)
were thawed at 4°C in 5 ml of 0.05 M potassium phosphate buffer, pH 7.6,
containing 2 mM dithiothreitol and 10 mM sodium molybdate. The suspension
was centrifuged at 12,000 gfor 20 min and the supernatant fraction was used for
assay ofreceptor activity. 250pl oflysate were incubated at 4°Cwith concentra-
tions of ['H]dexamethasone ranging from 2 to 100 nM with or without 50 pM
unlabeled dexamethasone. After an 18-h incubation, 50-p1 portions were added
to 100 pl ofdextran-coated charcoal suspension (1.0% Norit Aand 0.1% dextran
60C [60,000 molwt] in 1.5 mM MgCL) and vortexed. After 10 min at 4°Cthe
tubes were centrifuged, and the radioactivity in the supernatant fraction was
assayed.
Reagents
Ficoll Type 400, cytochalasin B, BSA, cycloheximide, AIB, 1lß-hydroxypro-
gesterone, and deoxycorticosterone were purchased from Sigma Chemical Co.,
St. Louis, Mo. Dexamethasone was a gift from Dr. WalterGall (Merck Chemical
Div., Merck & Co., Inc., Rahway, N.J.). Acetoorcein was supplied by Allied
Chemical Corp., Specialty Chemicals Div., Morristown, N. J. a[l"C]aminoiso-
butyric acid (51 .6 mCi/mmol), [1,2,4'H(N)]dexamethasone (20.9 Ci/mmol),
[methyl-'H]thymidine (6.7 Ci/mmol) and L-CH(G)]amino acid mixture (159.1
mCi/mg) were obtained from NewEngland Nuclear, Boston, Mass.
RESULTS
HTC cells can be readily enucleated by centrifuging the cells
through Ficoll gradients containing cytochalasin B. This drug
causes disruption of microfilaments, resulting in extrusion of
the nucleus; upon centrifugation, nuclei are separated from
cytoplasts on the basis of differences in buoyant density (24).
Cytoplasts form a discrete band in the 20% Ficoll region of the
gradients; intact cells, centrifuged through gradients without
cytochalasin B, are found in a less discrete area in the 22%
region of the gradients (Fig. 1). The yield of enucleated cells is
usually 60% but ranged from 40 to 80% (Table I). The efficiency
of enucleation is >90% as determined by counting cells and
cytoplasts in acetoorcein-stained preparations (Fig. 2) and by
measuring the incorporation of [3Hlthymidine by cells and
cytoplasts (Table I). Properties of intact cell controls (amino
acid incorporation, AID transport, and tyrosine aminotrans-
ferase induction) were the same whether they were centrifuged
through Ficoll gradients without cytochalasin B or were incu-
bated with cytochalasin in 15% Ficoll but not centrifuged in
the gradients. Thus, for most experiments, controls were cells
treated with cytochalasin B but not centrifuged; they were
washed free ofthe drug at the same time as the cytoplastswere
being prepared for use. During the course ofexperiments, both
cells and cytoplastswere maintainedin suspension in IM-BSA
supplemented as required with steroids or other compounds.
Characteristics of HTC Cytoplasts
Cytoplasts of HTC cells are rounded and are abouthalf the
size of intact cells (Fig. 2). The protein content of cytoplasts
was 47% that of whole cells; 83 ± 4 pg/cytoplast vs. 177 ± 12
pg/cell, mean t SE (Table I). Enucleated cells readily attach
to the surface of plastic tissue culture plates within 1-2 h but
fail to take on the polygonal shape assumed by intact cells.
PREPAR ATION OF CYTOPLASTS FROM HTC CELLS
30%
pellet - pellet
FIGURE 1
￿
Schematic diagram of preparation of cytoplasts from HTC
cells.
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their membrane integrity for up to 24 h, as judged by trypan
blue exclusion . Protein synthesis is reduced in enucleated cells;
the incorporation of 3H-amino acids into acid-precipitable
material by cytoplasts was 35% that ofintact cells, and this rate
decreased to <20% after 20-22 h (Table 1) . A similar decrease
in the rate of protein synthesis was reported by Ivarie et al.
(12) in HTC cells enucleated as monolayer cultures on cover
slips.
AIB Transport in HTC Cytoplasts
In initial studies with cytoplasts, we established that the
kinetic parameters of transport were the same as in intact cells.
Cells and cytoplasts incubated in serum-free medium with 0 .5
mM AIB showed the same time-course and extent of accumu-
lation of AIB during 180-min incubation (data not shown) . To
determine the kinetic parameters of transport by cells and
cytoplasts, we incubated duplicate suspensions of each for 10
min with concentrations of AIB ranging from 0 .1 mM to 10
% Yield
63 ± 4 (9)
mM . The AM saturation curves obtained were virtually iden-
tical for both intact cells and cytoplasts . Fig . 3 shows the data
rearranged as a Hofstee plot. The v. and apparentKm for
AIB transport in both cells and cytoplasts are the same : 12
nmol " min- ' - mg of protein- ' and 2.4 mM, respectively.
Thus, AIB transport appears to be preserved intact in enucle-
ated cells.
To determine whether AIB transport in enucleated cells were
inhibited by dexamethasone, we exposed cells and cytoplasts
in suspension to 0.1 uM or 50,uM dexamethasone for 8 h and
18 h and we measured the initial rates of AIB uptake. Cyto-
plasts are capable of active transport of AIB for as long as 18-
20 h, at a rate equal to that found in intact cells or two to three
times higher when expressed on a per milligram of protein
basis (Table 11) . In the presence of 0 .1 1M dexamethasone,
AM transport by intact cells was inhibited 80-90%, whereas
the steroid had no effect on the rate of transport by cytoplasts
(Table II and Fig . 4). Even 50,uM dexamethasone (a >100 x
saturating concentration of steroid) had little or no inhibitory
effect on transport in cytoplasts (Table 11) . When similar
Cytoplasts were prepared as described in Materials and Methods . Values for each entry are the mean ± SE, with the number of experiments in parentheses .
* Intact cell control : 177 ± 12 pg/cell .
FIGURE 2
￿
Photomicrograph of acetoorcein-stained preparations of cytoplasts (left) and intact cells (right) . x 400 .
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TABLE I
Characteristics ofHTC Cytoplast Preparations
% Enucleation Amino acid incorporation
(acetoorcein Thymidine % Excluding Protein
stain) incorporation trypan blue content* 1-3 h 7-12 h 20-22 h
% of intact cell control pg/cytoplast % of intact cell control
98 ± 0 .4 (7) 7 .4 ± 0.7 (12) 98 ± 0 .4 (10) 83 ± 4 (12) 35 ± 3 (11) 25 ± 1 (4) 17 ± 7 (3)experiments were carried out in monolayer cultures, 0.1 AM
dexamethasone inhibited AIB transport in intact cells by 45
t 3% after an 18-h incubation, whereas transport was inhibited
only 3 ± 1% in cytoplasts (mean ± SE, n = 7).
The time-course of the effect of steroids on transport in
cytoplasts was examined by incubating cells and cytoplasts in
serum-free medium with 0.1 [LM dexamethasone, 50 AM 11i8-
hydroxyprogesterone, and 50 AM deoxycorticosterone. The
results illustrated in Fig. 4 show that whereas all three steroids
inhibit transport ~80% in intact cells by 21 h, AIB uptake in
enucleated cells was either not inhibited or only minimally
inhibited by any of the three steroids. The nucleus appears to
be required to mediate the inhibition oftransport in HTC cells
by dexamethasone as well as other steroids.
It had been reported previously that dexamethasone did not
induce tyrosine aminotransferase activity in rat hepatoma cells
enucleated while attached to plastic plates, demonstrating the
essential role of the nucleus in the steroid-mediated induction
of this enzyme (7, 10, 12). The data of Table II illustrate the
effect of dexamethasone on tyrosine aminotransferase induc-
tion in our cytoplast preparations and confirm these earlier
reports. In this and five other experiments, dexamethasone
induced a sixfold or greater increase in transaminase in intact
cells, whereas in cytoplasts only a twofold or smaller increase
was observed. In our experiments, as in those previously re-
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FIGURE 3 Kinetics of AIB transport in HTC cells and cytoplasts.
Duplicate suspensions of cells (106/ml) or cytoplasts (5 x 106/ml)
were incubated for 10 min in serum-free medium with 0.5 jLCi/ml
['°C]AIB and unlabeled AIB added to final concentrations ranging
from 0.1 to 10 mM. Data from the experiment were rearranged for
a Hofstee plot and the best-fit lines were obtained by linear regres-
sion analysis (r2 is 0.94 for cytoplasts (C7), 0.97 for intact cells (O) .
TABLE II
Each datum represents the mean of duplicate samples from a single culture. Dex, dexamethasone.
* % Inhibition.
$ % Increase.
r
ported (12), the basal and "dexamethasone-induced" activities
ofthe enzyme in cytoplast preparations were always lower than
the basal uninduced activity in intact HTC cells. The apparent
induction of transaminase in cytoplast preparations could be
explained by a 2-5% contamination by intact cells.
Reversibility of Dexamethasone Inhibition
of Transport
When intact HTC cells previously incubated with dexameth-
asone are washed and resuspended in steroid-free medium, the
velocity of AM transport recovers from the dexamethasone-
inhibited level to that of untreated cells after 12-18 h. The
recovery of transport is blocked by addition of cycloheximide
(16). Tyrosine aminotransferase activity of cells from which
dexamethasone has been removed decreases with a half-time
of ~2.5 h (7). We therefore examined the reversibility of the
dexamethasone-inhibited AM transport in cytoplasts prepared
from dexamethasone-treated cells. Cells were incubated for 18
h in IM-BSA containing 0. I pM dexamethasone and enucleated
by centrifuging through Ficoll gradients also containing 0.1
AM steroid. The cytoplasts so obtained were resuspended in
conditioned IM-BSA containing dexamethasone, washed twice
with, and resuspended in, conditioned IM-BSA with or without
dexamethasone. As shown in Fig. 5 a, transport velocity in
dexamethasone-treated and washed intact cells increased in 2-
4 h to ~50% of control rate and reached control values by 12-
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FIGURE 4 Time-course of the effect of dexamethasone and other
steroids on AIB transport in cells and cytoplasts; cytoplasts with 0.1
AM dexamethasone (/), or 50 AM 11/3-hydroxyprogesterone (A), or
50 AM deoxycorticosterone (") ; intact cells with dexamethasone
("), or 11ß-hydroxyprogesterone (0), or deoxycorticosterone (0).
Suspensions of cells or cytoplasts were incubated in serum-free
medium with steroid and, at the times indicated, initial rates of
uptake of AIB were determined . Each point represents the mean of
duplicate samples from a single suspension culture.
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Incubation
time
h
Control
Transport velocity
0.1 Am Dex
nmol AIB
50 AM Dex
-min -' .mg-1
Tyrosine
Control
nmol
aminotransferase
0.1 AM Dex
product -min - ' .mg- '
8 1 .98 0.80 (60%)* 0.46 (77%)*
18 1 .54 0.29(81%) 0.20(87%) 34 214 (529%)$
8 4.34 4.63 (-) 4.17 (4%)
18 5.40 5.81 (-) 4.72 (13%) 7 17 (143%)20 h. By contrast, in cytoplasts prepared from steroid-treated
cells, there was only a modest increase in the velocity of
transport over that in cytoplastsmaintained in steroid-contain-
ing medium even after a 20-h incubation in steroid-free me-
dium (Fig. 5 b). In the same experiments, transaminase activity
ofwashed intact cellsdeclined 2.4-fold after5 h, and sevenfold
after 12 h; the enzyme activity in cytoplasts subjected to the
same treatment did not vary significantly from that in cyto-
plasts maintained in dexamethasone-containing medium (data
not shown). We conclude that the nucleus is required to
mediate the reversal of dexamethasone regulation of transport
velocity and transaminase activity in HTC cells.
Mechanism of the Loss of Dexamethasone
Regulation of Transport in Anucleate Cells
The inability of dexamethasone to inhibit AIB transport in
enucleated cells could be attributed to several factors. Cyto-
chalasin B itself might interfere in the sequence of events of
dexamethasone action (4); cytoplasts might be unable to take
up the steroid or to bind it specifically; and the reduced level
of protein synthesis in enucleated cells might prevent dexa-
methasone from producing inhibition. The following experi-
ments were performed to investigate these possibilities.
Incubation ofcells with cytochalasin B for 6 h had no effect
on transport. The results presented in Fig. 6 show that cyto-
chalasin at 10 ttg/ml (21 1LM) or 50,ug/ml (105 [LM) neither
significantly inhibited AIB transport itself nor affected the
inhibition of transport by dexamethasone.
Cytoplasts incubated with [3H]dexamethasone show specific,
cell-associated binding ofthe steroid that is blocked by a 1,000-
fold excess of unlabeled dexamethasone. However, the specific
binding of dexamethasone to cytoplasts was lower than that
found in whole cells, i.e., 41% of that in intact cells when
expressed per milligram ofprotein (Table III). Specific, satur-
able binding of [3H]dexamethasone is also demonstrable in
lysates prepared from anucleate cells. The apparent Kd of
dexamethasone binding in cytoplast lysates was the same as in
lysates of intact cells, but the maximal binding capacity was
reduced to ^-30% of that in control cell lysates (Table IV).
We have shown previously that the steroid regulation ofAIB
transport in HTC cells is blocked by high concentrations of
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FIGURE 5
￿
Reversibility of dexamethasone inhibition of AIB trans-
port in intact cells and cytoplasts. Suspensions of dexamethasone-
treated cells (1 .2 x 108/ml) andcytoplasts prepared from dexameth-
asone-treated cells (4 x 108/ml) were each divided into two por-
tions. One portion of cells (a) or cytoplasts (b) was maintained in
dexamethasone-containing medium (closed symbols); the second
portions were washed twice and resuspended in conditioned IM-
BSA without dexamethasone (open symbols) . Initial rates of AIB
uptake were measured at the times indicated.
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cycloheximide (16); thus the reduced rate of protein synthesis
observed in cytoplasts might account for the inability of dexa-
methasone to inhibit transport in these preparations. To further
investigate this possibility, we incubated HTC cells with a
concentration of cycloheximide (1 1LM) that decreased protein
synthesis in intact cells to the level observed in cytoplasts, and
we measured AIB transport in the presence of this concentra-
tion of cycloheximide, with and without 0.1 JIM dexametha-
sone. When protein synthesis was inhibited by 70% in intact
cells, the transport of AIB was still fully inhibited by dexa-
methasone. Thus, the loss of sensitivity of cytoplasts to dexa-
methasone and other corticosteroids probably cannot be ac-
counted for simply by the reduced levelofprotein synthesis in
enucleated cells.
DISCUSSION
Enucleated cells provide a particularly good means to investi-
gate the role of the nucleus in the regulation of cellular
ó
n.
rn
Z
m
Q
r
u J O
w
a
E
E
ó
E
2 4 6
TIME (hours)
FIGURE 6
￿
Effects of cytochalasin Bon dexamethasone inhibition of
transport. HTC cells (108/ml) were incubated in serum-free medium
with 10ILg/ml or 50ILg/ml cytochalasin B; 15 min after addition of
the drug, 0.1 /AM dexamethasone was added and initial rates of
transport were determined at the indicated times. O, Control;*,
dexamethasone; 0, 50ILg/ml cytochalasin B; ", 50 gg/ml cytochal-
asin B plus dexamethasone; ", 10 ug/ml cytochalasin B plus dexa-
methasone.
TABLE III
Binding of Dexamethasone to intact Cells and Cytoplasts
Binding
fmol - mg protein - '
Intact cells
￿
158 t 30
Cytoplasts
￿
66 t 8
Cells or cytoplasts in suspension in serum-free medium were incubated with
5 nM [3H]dexamethasone (20.9/ACi/nmol) t50AM unlabeled dexamethasone
for 40 min at 37'C. Cell-associated radioactivity was measured as described
in Materials and Methods. Data represent mean t SE from three experiments.
TABLE IV
Binding of Dexamethasone to Lysates of Intact Cells and
Cytoplasts
nM
￿
pmol " mg protein- '
Intact cells (4)
￿
0.76 t 0.05
￿
3.44 t0.48
Cytoplasts (2)
￿
0.76
￿
0.97
Binding of [3H]dexamethasone by lysates of intact cells and cytoplasts was
measured as described in Materials and Methods. Theapparent dissociation
constant (Ka mp) and total number of binding sites (n) were determined from
Scatchard analysis. The data represent the mean t SE of four experiments
with cells and the mean of twoexperiments with cytoplasts.functions. In particular, they are useful to examine the possi-
bility that dexamethasone, or the dexamethasone-receptor
complex, might have direct effects in the cytoplasm or on
membrane functions such as transport. HTC cells in suspension
can be conveniently and readily enucleated, with good yield
and a high degree of purity, and they retain many of the
properties of intact cells. They maintain theirmembrane integ-
rity, as judged by their ability to exclude trypan blue for at
least 24 h and to adhere to plastic. They synthesize protein, as
measured by incorporation of amino acids into acid-precipita-
ble material, though at a rate reduced from that of intact cells.
We have shown that cytoplasts actively transport AIB and that
the kinetic parameters of transport are unchanged from those
ofwhole cells. Enucleated cells also show plasminogen activa-
tor activity, another membrane-associated property; glucocor-
ticoid regulation of this property is also lost in cytoplasts (1),
However, steroids fail to regulate AIB transport in enucle-
ated cells. The velocity of AIB transport is not inhibited by
dexamethasone even at concentrations as high as 50 [M, and
only slightly by deoxycorticosterone or l lß-hydroxyprogester-
one at concentrations that produce maximal inhibition in intact
cells. Furthermore, AIB uptake by cytoplasts prepared from
cells previously incubated with dexamethasone does not in-
crease to its uninhibited level when the cytoplasts are washed
free of the steroid, in contrast to the case with intact cells. In
these same experiments, we have also shown that tyrosine
aminotransferase activity of cytoplasts is neither induced by
dexamethasone nor deinduced by removal of steroid from the
incubation medium, confirming previous reports (7, 10, 12).
We have examined a number of possibilities to explain the
failure of dexamethasone to regulate AIB transport in cyto-
plasts. Cytochalasin B disrupts microfilaments (24) and is
known to inhibit carbohydrate transport in a number of cell
lines (6, 17). However, we have shown that this agent by itself
has no effect on AIB transport, nor does it alter regulation of
transport by dexamethasone in intact cells. Enucleated cells
exhibit a decreased level of protein synthesis, and it has been
demonstrated that the dexamethasone inhibition of transport
can be blocked by cycloheximide (16). However, intact cells
incubated with sufficient cycloheximide to inhibit protein syn-
thesis to 30% of control level still show maximal inhibition of
transport by dexamethasone. It seems unlikely, then, that the
decreased level of protein synthesis in cytoplasts per se can
account for the failure of dexamethasone to inhibit transport
in these preparations.
Cytoplasts might be unresponsive to corticosteroids because
of decreased steroid binding activity resulting from the enu-
cleation procedure. Receptor proteins could be lost during
enucleation or could be degraded or altered in some way that
might change their steroid binding properties. Intracellular
proteases released during the procedure could inactivate or
destroy existing receptors, and the reduced level of protein
synthesis mightprevent synthesis ofadditional receptors. How-
ever, we have demonstrated saturable, specific binding of
dexamethasone by cytoplasts and by cell-free lysates prepared
from cytoplasts, although the amount bound is less than that
bound by intact cells. In HTC cells, glucocorticoid responsive-
ness is directly proportional to receptor occupancy, i.e., there
is no evidence for "spare receptors" (21). Therefore, we might
expect decreased dexamethasone binding to be reflected in a
decreased magnitude of response, but a 60-70% decrease in
binding should not explain a total loss of responsiveness. It is
also possible that cytochalasin B and/or the enucleation pro-
cedure interferes with the normal activation of receptors after
steroid binding. The observations shown in Fig, 6 appear to
exclude the former possibility. Cytochalasin B, even at a con-
centration five times greater than that used for enucleation,
does not interfere with the dexamethasone inhibition of AIB
transport in intact cells, indicating that receptor activation and
translocation into the nucleus remain intact.
We have previously suggested that dexamethasone may in-
duce the synthesis of a labile protein that enhances the degra-
dation ofa rate-limitingcomponent ofthe transport mechanism
(8, 16). There is evidence that protein degradation in HTC cells
is dependent upon protein synthesis and can be blocked by
cycloheximide (5, 9). In addition, in HTC cells enucleation
results in a reduction in the rate of degradation of tyrosine
aminotransferase and a small number of other unstable pro-
teins (7). These results imply the involvement of some nuclear
component in the turnover of HTC cell proteins. Thus the loss
of glucocorticoid regulation of amino acid transport in cyto-
plasts could result from the absence of a nuclear component
required for degradation.
We conclude that an intact nucleus is required for the
glucocorticoid regulation of amino acid transport in HTC cells.
This may reflect a direct nuclear action of the steroid and/or
a requirement for the nucleus for protein degradation.
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